Live Markets »News & Advice»Market News»Market News Details
Market News Details

US drugmaker Pfizer says it will split business into three units

Reuters/Bengaluru 11 Jul 18 | 10:43 PM

Photo courtesy: Reuters

US drugmaker Pfizer said on Wednesday that it would split its business into three units and one of them would include a new hospital business segment.

Related Stories

    No Related Stories Found
Widgets Magazine

The three new units are innovative medicines, established medicines and consumer healthcare. The company said the innovative medicines business and consumer healhcare would together comprise about three—quarter of its revenue based on 2017 results.

“This new structure represents a natural evolution of these businesses, given the ongoing strength of our in-market products and our late-stage pipeline and the expected significant reduction in the impact of patent protection losses post—2020," Pfizer’s Chief Executive Officer Ian Read said.

ALSO READ: Pfizer rolls back drug price hikes temporarily after talking with Trump

The move comes a day after the company decided to defer drug price increases for no more than six months, after US. President Donald Trump criticized Pfizer and other US drugmakers for raising list prices of some medicines.

The established medicines unit would include the majority of the company’s off-patent brands, including Viagra and neurological disease treatment Lyrica.

ALSO READ: Pfizer hits an over two-year high ahead of March quarter results

Pfizer said a loss of exclusivity for blockbuster fibromyalgia treatment Lyrica is expected to occur in or after December 2018. The changes would come into effect at the start of fiscal 2019.

Widgets Magazine


Company Price Gain (%)
Sun Pharma.Inds.559.902.72
Reliance Inds.1,128.552.23
ICICI Bank266.001.84
Axis Bank534.451.36


Currently No Poll Available.

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine